MoneyWorks4Me

Dr. Lal PathLabs submits analyst meet intimation

27 Mar 2023 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).

The above information is a part of company’s filings submitted to BSE.
Peers